330
Participants
Start Date
Not specified
Study Completion Date
April 30, 2003
ALVAC(2)120(B,MN)GNP (vCP1452)
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
HIV Prevention & Treatment CRS, New York
NY Blood Ctr./Bronx CRS, The Bronx
Univ. of Rochester HVTN CRS, Rochester
Project Brave HIV Vaccine CRS, Baltimore
Johns Hopkins Bloomberg School of Public Health, Ctr. for Immunization Research, Project SAVE-DC, Baltimore
Infectious Diseases Physicians, Inc., Annandale
Alabama Vaccine CRS, Birmingham
Vanderbilt Vaccine CRS, Nashville
Saint Louis Univ. School of Medicine, HVTU, St Louis
San Francisco Dept. of Public Health, San Francisco Gen. Hosp., San Francisco
FHCRC/UW Vaccine CRS, Seattle
San Francisco Vaccine and Prevention CRS, San Francisco
Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore, Baltimore
NY Blood Ctr./Union Square CRS, New York
Brigham and Women's Hosp. CRS, Boston
Fenway Community Health Clinical Research Site (FCHCRS), Boston
Miriam Hospital's HVTU, Providence
National Institute of Allergy and Infectious Diseases (NIAID)
NIH